Horiguchi, Hiroshi http://orcid.org/0000-0002-9536-5875
Suzuki, Eiji
Kubo, Hiroyuki
Fujikado, Takashi
Asonuma, Sanae
Fujimoto, Chihomi
Tatsumoto, Muneto
Fukuchi, Takeo
Sakaue, Yuta
Ichimura, Mika
Kurimoto, Yasuo
Yamamoto, Midori
Nakadomari, Satoshi
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP18K16939)
Japan Agency for Medical Research and Development (15dk0310013h0003)
Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder
Article History
Received: 5 June 2020
Accepted: 23 October 2020
First Online: 9 January 2021
Conflicts of interest
: H. Horiguchi, Grant (Next Vision); E. Suzuki, None; H. Kubo, Grant (Next Vision); T. Fujikado, Grant (Next Vision); S. Asonuma, Grant (Next Vision); C. Fujimoto, Grant (Next Vision); M. Tatsumoto, Grant (Next Vision); T. Fukuchi, Grant (Santen, HOYA, Atsuzawa Proteze, Shiga Medical Instruments, Union Medical, Retina Kitanihon, Abbott, Otsuka, Senju, Alcon, Kowa, Next Vision), Lecture fee (Santen, Abbott, Otsuka, Senju, Alcon, Kowa, Pfizer, Glaukos, AbbVie, Nitten, Alcon, Nidek, Novartis); Y. Sakaue, Grant (Next Vision); M. Ichimura, Grant (Next Vision); Y. Kurimoto, Grant (TOMEY, Santen, HOYA, Novartis, AMO, Senju, Bayer, Kowa, Next Vision), Financial support (Santen, HOYA, Novartis, AMO, Senju), Lecture fee (Bayer, Kowa, Alcon); M. Yamamoto, Grant (Next Vision); S. Nakadomari, Grant (Next Vision, Tokai Optical).